Background: Inflammatory bowel disease (IBD) care and education might differ around Europe. Therefore, we conducted this European Variation In IBD PracticE suRvey (VIPER) to investigate potential differences between countries. Methods: This trainee-initiated survey, run through SurveyMonkey®, consisted of 47 questions inquiring basic demographics, IBD training, and clinical care. Results were compared according to gross domestic product (GDP) per capita, for which countries were divided into 2 groups (low/high income, according to the World Bank). Results: The online survey was completed by 1,285 participants from 40 European countries, with a majority of specialists (65.3%) working in academic institutions (50.4%). Significant differences in IBD-specific training (55.9% vs. 38.4%), as well as availability of IBD units (58.4% vs. 39.7%) and multidisciplinary meetings (73.2% vs. 40.1%), were observed between respondees from high and low GDP countries (p < 0.0001). In high GDP countries, IBD nurses are more common (85.9% vs. 36.0%), also mirrored by more nurse-led IBD clinics (40.6% vs. 13.7%; p < 0.0001). IBD dieticians (33.4% vs. 16.5%) and psychologists (16.8% vs. 7.5%) are mainly present in high GDP countries (p < 0.0001). In the current COVID era, telemedicine is available in 73.2% versus 54.1% of the high/low GDP countries, respectively (p < 0.0001). Treat-to-target approaches are implemented everywhere (85.0%), though access to biologicals and small molecules differs significantly. Conclusion: Much variability in IBD practice exists across Europe, with marked differences between high and low GDP countries. Further work is required to help address some of these inequalities, aiming to improve and standardize IBD care and training across Europe.

1.
M'Koma
AE
.
Inflammatory bowel disease: an expanding global health problem
.
Clin Med Insights Gastroenterol
.
2013
;
6
:
33
47
.
2.
Chang
JT
,
Longo
DL
.
Pathophysiology of inflammatory bowel diseases
.
N Engl J Med
.
2020
;
383
(
27
):
2652
64
.
3.
Ananthakrishnan
AN
.
Epidemiology and risk factors for IBD
.
Nat Rev Gastroenterol Hepatol
.
2015
;
12
(
4
):
205
17
.
4.
Molodecky
NA
,
Soon
IS
,
Rabi
DM
,
Ghali
WA
,
Ferris
M
,
Chernoff
G
,
.
Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review
.
Gastroenterology
.
2012
;
142
(
1
):
46
54.e42; quiz e30
.
5.
Abraham
C
,
Cho
JH
.
Inflammatory bowel disease
.
N Engl J Med
.
2009
;
361
(
21
):
2066
78
.
6.
Kaplan
GG
.
The global burden of IBD: from 2015 to 2025
.
Nat Rev Gastroenterol Hepatol
.
2015
;
12
(
12
):
720
7
.
7.
Torres
J
,
Bonovas
S
,
Doherty
G
,
Kucharzik
T
,
Gisbert
JP
,
Raine
T
,
.
ECCO guidelines on therapeutics in crohn's disease: medical treatment
.
J Crohns Colitis
.
2020
;
14
(
1
):
4
22
.
8.
Magro
F
,
Gionchetti
P
,
Eliakim
R
,
Ardizzone
S
,
Armuzzi
A
,
Barreiro-de Acosta
M
,
.
Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders
.
J Crohns Colitis
.
2017
;
11
(
6
):
649
70
.
9.
Maaser
C
,
Sturm
A
,
Vavricka
SR
,
Kucharzik
T
,
Fiorino
G
,
Annese
V
,
.
ECCO-ESGAR guideline for diagnostic assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications
.
J Crohns Colitis
.
2019
;
13
(
2
):
144
64
.
10.
Barreiro-de Acosta
M
,
Gutiérrez
A
,
Zabana
Y
,
Beltrán
B
,
Calvet
X
,
Chaparro
M
,
.
Inflammatory bowel disease integral care units: evaluation of a nationwide quality certification programme. The GETECCU experience
.
United European Gastroenterol J
.
2021
;
9
(
7
):
766
72
.
11.
Kapasi
R
,
Glatter
J
,
Lamb
CA
,
Acheson
AG
,
Andrews
C
,
Arnott
ID
,
.
Consensus standards of healthcare for adults and children with inflammatory bowel disease in the UK
.
Frontline Gastroenterol
.
2020
;
11
(
3
):
178
87
.
12.
Europe WHO
.
Inequalities in health system performance and their social determinants in Europe 2021
. Available from: https://www.euro.who.int/en/data-and-evidence/equity-in-health-project/inequalities-in-health-system-performance-and-their-social-determinants-in-europe.
13.
Fiorino
G
,
Lytras
T
,
Younge
L
,
Fidalgo
C
,
Coenen
S
,
Chaparro
M
,
.
Quality of care standards in inflammatory bowel diseases: a European crohn’s and colitis organisation [ECCO] position paper
.
J Crohns Colitis
.
2020
;
14
(
8
):
1037
48
.
14.
Nixon
J
,
Ulmann
P
.
The relationship between health care expenditure and health outcomes. Evidence and caveats for a causal link
.
Eur J Health Econ
.
2006
;
7
(
1
):
7
18
.
15.
Hitiris
T
,
Posnett
J
.
The determinants and effects of health expenditure in developed countries
.
J Health Econ
.
1992
;
11
(
2
):
173
81
.
You do not currently have access to this content.